GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's money market investment for the quarter that ended in Dec. 2013 was $-62.14 Mil. It means Synageva BioPharma Corp paid $62.14 Mil to invest on the money market.
Compared with last quarter ($-216.87 Mil in Sep. 2013 ), Synageva BioPharma Corp paid less money to invest on the money market in Dec. 2013 ($-62.14 Mil).
Money Market Investments carried on banks' balance sheet.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data